Texas Yale Capital Corp. Novo Nordisk A S Transaction History
Texas Yale Capital Corp.
- $2.47 Billion
- Q4 2024
A detailed history of Texas Yale Capital Corp. transactions in Novo Nordisk A S stock. As of the latest transaction made, Texas Yale Capital Corp. holds 33,221 shares of NVO stock, worth $2.96 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
33,221
Previous 34,826
4.61%
Holding current value
$2.96 Million
Previous $4.15 Million
31.09%
% of portfolio
0.12%
Previous 0.18%
Shares
10 transactions
Others Institutions Holding NVO
# of Institutions
1,882Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.78 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.38 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.16 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.13 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$1.09 Billion0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $201B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...